Pharmafile Logo
Pharmafocus logo
Advanced Search

Onglyza cleared for use with insulin

November 29, 2011
Sales and Marketing AstraZeneca, Merck, Onglyza, diabetes, insulin

European regulators have approved a licence extension for Bristol-Myers Squibb and AstraZeneca’s type II diabetes treatment Onglyza. The oral DPP-4 …

News

Catalent Pharma Solutions Appoints New Vice President and General Manager – Sterile Technologies

November 28, 2011
Manufacturing and Production

Catalent Pharma Solutions, Inc. announced the appointment of Jonathan Arnold as Vice President and General Manager – Sterile Technologies effective …

Appointment

Munro & Forster win PRCA Health and Wellbeing Award

November 28, 2011
Medical Communications COPD, ERS, Munro & Forster, PRCA

Healthcare comms agency Munro & Forster has won an industry award for its innovative World Spirometry Day Campaign for the …

News

Janssen sets up new mental health social networking site

November 28, 2011
Medical Communications J&J, JJ, Janssen, NHS

Janssen and the NHS Confederation have established a new mental health social networking site. The service, which will be free …

News
Gardasil picture

UK government drops Cervarix for Gardasil

November 28, 2011
Sales and Marketing Cervarix, GSK, Gardasil, MSD, Sanofi

The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …

News

UCB appoints Peter Theil as head of non-clinical development

November 28, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB

Peter Theil has joined UCB as its new vice president and head of non-clinical development for the firm’s new medicines …

Appointment

Pfizer to acquire skin specialist firm Excaliard

November 28, 2011
Sales and Marketing EXC 001, Excaliard, Pfizer

Pfizer will acquire skin specialist Excaliard Pharmaceuticals as the firm looks to further diversify its pipeline. Financial terms of the …

News

Shire facility could answer rare disease drug shortage

November 27, 2011
Manufacturing and Production Fabry disease, Gaucher, Shire, Vpriv

Shire has filed applications with the European and US regulators to produce its Gaucher disease drug Vpriv (velaglucerase alfa) at …

News

Pfizer’s Loughbeg first pharma facility to meet green standard

November 27, 2011
Manufacturing and Production ISO 50001, Loughbeg, Pfizer, environmental

A Pfizer facility in Ireland has become the first pharmaceutical plant in the world to meet a tough new standard …

News

The changing of the guard – Q3 round up

November 25, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy

 PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …

Feature

Quality fears prompt cancer drug recalls

November 25, 2011
Manufacturing and Production Ben Venue, EU, Hong Kong, manufacturing

Regulatory authorities around the world are recalling cancer drugs manufactured by Boehringer Ingelheim’s Ben Venue Laboratories subsidiary after an inspection …

News

Mixed results for UK in international health survey

November 25, 2011
Sales and Marketing NHS, OECD, healthcare

The NHS in England does not perform well on some patient outcomes for cancer, stroke and respiratory diseases given the …

News
NICE hq pic

NICE okays Eliquis for blood clots after surgery

November 25, 2011
Research and Development, Sales and Marketing BMS, Eliquis, NICE, Pfizer

NICE is recommending Pfizer and Bristol-Myers Squibb’s Eliquis for blood clots after surgery. Specifically, NICE has said that Eliquis (apixaban) …

News
screen_shot_2011-11-24_at_13

RSA announces raft of new appointments

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

RSA, the global life sciences executive search and interim management firm, has announced a series of new appointments. RSA Switzerland …

Appointment

Adaptive Trial Design

November 24, 2011
Research and Development

Despite the burgeoning interest in Adaptive Trial Design (ATD), an extremely powerful tool when used effectively in the appropriate circumstances, …

Feature
White paper

NICE confirms ‘no’ for colorectal cancer drugs

November 24, 2011
Sales and Marketing Erbitux, NICE, Vectibix, avastin, colorectal cancer

 

News
glyn_edwards

Glyn Edwards appointed interim chief executive of the BioIndustry Association

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards

The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …

Appointment
Lucentis image

Lucentis not backed by NICE for new licence

November 24, 2011
Sales and Marketing Lucentis, NICE, Novartis, Ozurdex

NICE has not recommended Novartis’ eye disease drug Lucentis due to ‘gaps and uncertainties’ in the manufacturer’s submission. In draft …

News
screen_shot_2011-11-24_at_09

Professor Sir Michael Rawlins reappointed as NICE chairman

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins

The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …

Appointment

Private sector role in NHS commissioning opposed

November 23, 2011
Medical Communications, Sales and Marketing BMA, CCGs, NHS, PCT clusters

Private firms could be allowed to support clinical commissioning groups, the new NHS budget holders in England.New draft guidance from the Department …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026